Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
about
Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic SyndromeThe non-immunosuppressive management of childhood nephrotic syndromeMembranous nephropathy: not just a disease for adultsPro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapyThe Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapseSyncope in a patient with minimal change disease without nephrotic-range proteinuria.Serum D-dimer is a potential predictor for thromboembolism complications in patients with renal biopsy.Utility of plasma fibrinogen in the differential diagnosis of thyrotoxicosis.Healthcare burden of venous thromboembolism in childhood chronic renal diseases.Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosisDisease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic SyndromeAKI in Children Hospitalized with Nephrotic Syndrome.Neurological Manifestations of Renal Diseases in Children in Qazvin/ IranThe emerging role of coagulation proteases in kidney disease.Clinical use and the Italian demand for antithrombin.Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury.Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.Childhood Nephrotic Syndrome Management and Outcome: A Single Center Retrospective Analysis.Venous thromboembolism in pediatric nephrotic syndrome.The role of complement in membranous nephropathy.The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.Premature mortality due to nephrotic syndrome and the trend in nephrotic syndrome mortality in Japan, 1995-2014.Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.Nephrotic syndrome in infants and children: pathophysiology and management.Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy.Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome.Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic SyndromeThrombosis of the Abdominal Veins in Childhood.Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome.An adult case of nephrotic syndrome presenting with pulmonary artery thrombosis: a case report.Nephrotic syndrome complicated with deep venous thrombosis in the upper extremities.Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome.Nephrotic syndrome complicated with portal, splenic, and superior mesenteric vein thrombosisOver- or underfill: not all nephrotic states are created equal.Nephrotic syndrome and stroke.Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study.Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.
P2860
Q26770245-99453B88-0816-4848-86E0-75814795321BQ26778157-0A4F3871-0AB1-4692-A9B8-72B9EDE8778CQ26866206-F6448BD9-7831-4686-B4C2-0AF4B8AF974FQ27015909-00050E20-5A0D-433B-8C46-738EE5348148Q29994584-74BCDAFB-A94A-4C3E-932C-DE616E34A673Q33168844-F23C4193-E64C-45A0-ABAB-CE52B19E12D3Q33881299-4608DD23-9EEE-429D-BD68-FC552A7A89A3Q35173816-C618E9CE-E9B7-480D-8E5B-82C292FB5C44Q35220516-201CC916-88B7-4770-A2A1-DB1657B814EDQ35802182-1D0A9367-722B-4DFD-8486-D65C9A10D4F8Q36314964-92B6B88A-895D-4602-9F18-0CB586720733Q36349462-C9B5332D-5E47-48F0-AF6C-423D011FA0E3Q37055543-87EB06A8-E593-4EB7-B9FC-889CFBA6866BQ37066587-1ABA49CE-1DB3-4A13-B3E6-CF00452045DDQ37370321-3AD98EFF-841B-4C36-8153-5D2591E992C4Q37395624-A3EA4DBC-EF76-496F-8D76-127135F75F05Q37621561-B31B4CA3-87E8-4BDD-BAD2-17D097B21958Q37689858-2E6AEFB4-7D89-4C6B-B465-B74256290E09Q38118114-DC1AD267-845E-426E-B665-ABD94764B627Q38155652-92AE1743-FEF5-4C74-B46E-ED41CAB059ECQ38383524-329084AB-577E-4633-8D41-8CDF50DDEDFAQ38717036-63A06E09-824A-46DA-B554-D0EBD2C2E22FQ38800258-528AB20B-F309-4FB8-9DD1-43067DCF8C68Q38821066-67AC0959-B685-4E17-B05B-529D18DD9586Q38829694-216441AB-C7AE-47B7-AE26-D64804DE4789Q40039238-797B2E79-DBF5-45C4-A582-92481A00CA83Q40760716-8BD8B8E2-642A-4778-A58C-032E722BA5F1Q41185833-0A78460C-287B-43A2-90D8-006BD306420BQ41232321-C89261F4-81DB-43C8-B5FC-8D9034EA0C01Q41457449-2EAD2CCF-FBD2-48E2-8ED5-D1146288D8A1Q41536987-CD51B0A4-4717-4140-B8A1-33AED1217E0EQ41790110-2E003B6B-C173-4D39-96E0-FBF85A4FFD0BQ42123822-A80143EB-4A43-4F7D-B31B-A01D7E0E1872Q42247724-CDBBD325-5675-4973-840E-C6DE12331973Q42264786-C986D72A-32AE-41AE-AE87-20C87FF6935FQ42287825-DACB48B9-D131-490C-BDC4-6BFF3482892BQ44201195-91F1CA7A-F3D6-4F0C-B107-8B8EF4C93B0DQ45381894-50F65B5A-A1F6-4E7B-BDAD-32D4B7E96CCBQ45881550-D56E6E26-487A-4C7F-88B3-61406218F4B3Q46030902-42B060D7-CD96-4BBB-8B3D-162070C44FA2
P2860
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@ast
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@en
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@nl
type
label
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@ast
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@en
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@nl
prefLabel
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@ast
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@en
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@nl
P2093
P2860
P3181
P356
P1476
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease
@en
P2093
B. A. Kerlin
W. E. Smoyer
P2860
P304
P3181
P356
10.2215/CJN.10131011
P407
P577
2012-03-01T00:00:00Z